Author name: euretina

Future Directions

Future Directions In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus discuss promising treatment strategies, including gene-specific targeted therapies and broader, agnostic approaches that may address multiple genes or underlying pathogenic mechanisms. They also provide an overview of ongoing cell […]

Future Directions Read More »

Managing IRD Patients

Managing IRD Patients In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus underscore the importance of early detection, regular follow-ups, and referrals to specialized centers, enabling IRD patients to receive comprehensive assessments, including functional and genetic testing. They also discuss

Managing IRD Patients Read More »

Patient Communication

Patient Communication In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black discuss key strategies for effectively communicating IRD diagnoses to patients. They address common misconceptions, clarify essential terminology, and emphasize the vital role of genetic counselors in guiding patients towards

Patient Communication Read More »

Diagnosing IRDs

Diagnosing IRDs In this episode of the EURETINA IME video interview series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black explore the complexities of diagnosing IRDs, emphasizing the importance of a multidisciplinary approach. They discuss key diagnostic elements, challenges, and the potential of artificial intelligence to enhance diagnostic efficiency.

Diagnosing IRDs Read More »

Implementing GA Treatments

Implementing GA Treatments In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof.

Implementing GA Treatments Read More »

Scroll to Top